August 2, 2019 : Business Articles and Interviews | Outlook Business
Tricky Transition
Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs

Pixtory / Graphically SpeakingBots at work

Bots may soon take India’s jobs in outsourcing. A report warns of a “digital disorder”

Enterprise / Big IdeaImpaired no more

Sonant Technologies’ device empowers the speech-impaired by giving them a voice

Enterprise / Big IdeaPartners in grime

Sewage treatment plants that mimic nature could heal our lakes, stop deaths in poorly aired sewage systems and save us money

Enterprise / FeatureSecond to None

The used car market in India is disrupting the auto industry, already vrooming ahead of new car sales

Strategy / FeatureE-tail gets Real

After strengthening their presence online, e-commerce players sniff out a lucrative market offline

Markets / TrendMixed reading

Thyrocare Technologies promoter A Velumani mops up stock worth Rs.310 million in 2019, so far

Markets / TrendIs there more downside to consumer staple stocks?

Facing sluggish volume growth due to slowdown in rural consumption, FMCG companies reported muted numbers in Q4FY19

Markets / FeatureThe golden middle

In a rapidly changing digital world, mid-cap IT firms have more headroom to grow than large-caps

Markets / FeatureCalm After the Storm

A well-managed insurance company turned out to be a risky stock to own. But it may be safe to set sail again, with Max Financial Services

The Big Story / Lead StoryNew growth model

Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?


Netflix highlights the depth and width of its content library through a series of ten ads